EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The mechanism of zolpidem and ramelteon to treat insomnia

Shengqi Cao

MedScien · 2025

DOI: 10.61173/0qqype23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MedScien, 2025. Verfasst von Shengqi Cao. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Insomnia, characterized by difficulty in getting or keeping sleep, has a serious impact on daytime performance and health. Zolpidem, a GABA-A receptor modulator, reduces sleep latency and increases sleep duration, making it suitable for short-term use. Ramelteon, a melatonin receptor agonist, regulates circadian rhythms and is effective for chronic insomnia, but is not addictive. The choice between zolpidem and ramelteon depends on the type of insomnia, and non-pharmacological treatments such as cognitive-behavioral therapy are recommended as a first choice. It is hoped that future treatments for insomnia will become safer and more personalized, combining medication with behavioral therapy to supplement treatment.

Zitieren

APA

Cao, S. (2025). The mechanism of zolpidem and ramelteon to treat insomnia. MedScien. https://doi.org/10.61173/0qqype23

Vancouver

Cao S. The mechanism of zolpidem and ramelteon to treat insomnia. MedScien. 2025. doi:10.61173/0qqype23

BibTeX
@article{Cao2025,
  author = {Cao, Shengqi},
  title = {The mechanism of zolpidem and ramelteon to treat insomnia},
  journal = {MedScien},
  year = {2025},
  doi = {10.61173/0qqype23}
}
Kostenlos starten →